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Abstract:  Our understanding of the movement of water through cell membranes has been greatly advanced by the   
discovery of a family of water-specific, membrane-channel proteins: the Aquaporins (AQPs). These proteins are present 
in organisms at all levels of life, and their unique permeability characteristics and distribution in numerous tissues indicate 
diverse roles in the regulation of water homeostasis. 
Phenotype analysis of AQP knock-out mice has confirmed the predicted role of AQPs in osmotically driven transepithelial 
fluid transport, as occurs in the urinary concentrating mechanism and glandular fluid secretion. Regarding their expression 
in nervous system, there are evidences suggesting that AQPs are differentially expressed in the peripheral versus central 
nervous system and that channel-mediated water transport mechanisms may be involved in cerebrospinal fluid formation, 
neuronal signal transduction and information processing. 
Moreover, a number of recent studies have revealed the importance of mammalian AQPs in both physiological and  
pathophysiological mechanisms and have suggested that pharmacological modulation of AQP expression and activity  
may provide new tools for the treatment of variety of human disorders in which water and small solute transport may be 
involved.  
For all the AQPs, new contributions to physiological functions are likely to be discovered with ongoing work in this  
rapidly expanding field of research. 
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1. WATER IN LIVING CELLS 
  Water is the main component of all living cells, and wa-
ter exchange may be considered as a property of life. At the 
extracellular level, water is the main component of biological 
fluids; at the extracellular/intracellular interface, water ex-
change through the plasma membrane maintains the osmo-
larity of the cytoplasm and thus the integrity of the cells. At 
the molecular level, water is involved in the configuration of 
some important molecules. Indeed, water is a polar molecule 
and displays electrostatic properties, forming hydrogen 
bonds, that confer its capacity of interacting with solutes but 
also participates in the stability and specificity of protein-
protein and protein-DNA interaction. Water is also involved 
in metabolic processes such as cellular respiration and pho-
tosynthesis in plants. 
  The biological membrane surrounding living cells is not 
a pure lipid bilayer. There is a simple diffusion of water 
through a lipid membrane but it does not explain the high 
velocity of water exchange observed, for instance, in red 
blood cell membrane, nor the low energy activation observed 
for such phenomena [2]. Furthermore, first measurements of 
water movement and its effective re-absorption through the 
kidney proximal tubules comforted the hypothesis of some  
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specific pathways for water molecules trafficking [19]. In 
accordance to previous data, these observations strengthened 
the idea of existence of selective water pores in biological 
membrane. Many clues of their presence were then provided 
in a broad variety of organs such as in salivary glands, eyes 
and brain [26]. 
2. DISCOVERY OF AQUAPORINS 
  The existence of water channel proteins was suspected 
long before their identification from experiments showing 
that red blood cells membranes are more permeable to water 
than expected from water diffusion through a lipid bilayer 
[87]. Further studies revealed that the water permeability of 
red blood cells could be inhibited by mercurial compounds 
(HgCl2) and that the inhibition could be reversed with 
chemical reducing agents. Taken together, these studies   
suggested that water transport occurs through a protein that 
has free sulfhydryl groups that are accessible to mercury 
[57].  
  The molecular basis for the water transport phenomenon 
was first identified by the team of Peter Agre. A 28 kDa pro-
tein, subsequently known as CHIP28 and re-named AQP1 
for Aquaporin 1, was purified from red blood cells and renal 
proximal tubule membranes [3, 22] and then characterized as 
a water channel showing that Xenopus Laevis oocytes ex-
pressing AQP1 in their plasma membrane were far more 
susceptible to osmotic lysis than non-expressing oocytes 
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  The corresponding cDNA was cloned and the deduced 
aminoacid sequence showed high homology with the ancient 
family of membrane channels, MIP for Major Intrinsic Pro-
tein [76] and, in particular, with MIP of the eye lens [32], 
which was later named AQP0.  
  In parallel, studies on the antidiuretic hormone (ADH) 
responsive cells in amphibian urinary bladder led to the idea 
that changes in water permeability in ADH-sensitive cells 
result from the insertion in apical plasma membrane of new 
components that contains channels for water [35] and so to 
the discovery of the second water channel protein, AQP2 
[68, 69]. Since 1993 several AQPs have been discovered in 
organisms for all kingdoms of life [85], including unicellular 
organisms (bacteria, yeast and protozoa) and multicellular 
ones (plants, animals, and humans) underlying the impor-
tance of these channels for life [46]. 
  A subsequent functional characterization has given   
new insights regarding the role of these proteins that for 
some members is not restricted or not linked to water move-
ment but to the transport of non-ionic and/or small neutral 
solutes.  
3. THE AQUAPORIN FAMILY 
  The water channel family is still growing with 13 mem-
bers ubiquitously distributed in mammalian tissues [47, 94]. 
Eleven of the 13 members have been identified from various 
mammalian tissue including the nervous system, kidney, 
gastrointestinal tract, skin and respiratory tract [52, 53].  
  These channels have been highly conserved throughout 
evolution and the family is now divided accordingly to se-
quence homology and permeability [5] into: aquaporins and 
aquaglyceroporins.  
  The subgroup of aquaporins is composed of AQP0, 
AQP1, AQP2, AQP4, AQP5, AQP6 and AQP8 and is con-
sidered to be mainly permeable to water with a high flow 
rate. A few of these pure water channels are also permeable 
to anion (AQP6), volatile solutes such as CO2 for AQP1 [20] 
and ammonia for AQP8 [43]. Water diffusion through AQPs 
is inhibited by mercury, except AQP4 which is a mercury-
insensitive AQP [5]. 
  The second subgroup aquaglyceroporins, is composed of 
AQP3, AQP7, AQP9, AQP10 and bacterial glycerol facilita-
tor (Glpf) [10]. These channels are permeable to water, glyc-
erol and urea. AQP9, a member of this group, was also sur-
named “neutral channel” [92]. Indeed, the presence of AQP9 
in Xenopus Oocytes or proteoliposomes injected facilitated 
the diffusion of water, but also polyols (glycerol, mannitol, 
and sorbitol), purines (adenine), pyrimidines (uracil and 
chemotherapeutic agent 5-fluorouracil) and monocarboxy-
lates (lactate, -hydroxybutyrate) [18, 41, 48, 92]. However, 
the osmotic water coefficient for AQP9 is lower than in a 
pure water channel like AQP4 [18]. In addition AQP9 facili-
tates metalloid transport further suggesting that AQP9 may 
be a major route of arsenite uptake into mammalians cells 
[54]. 
  In addition to aquaporins and aquaglyceroporins, a third 
subfamily of related proteins was discovered later by Ishi-
bashi [40], being called “superaquaporins” or “subcellular 
aquaporins”. Originally, in this subfamily were included the 
mammalians AQP11 and 12; recently, the subfamily was 
renamed as “unorthodox AQPs” and mammalian AQP6 and  
8 were also included. Few papers have been published on 
them and this may be because their functions have not been 
clearly shown and they seem to be localized inside the cells 
[71]. 
4. MOLECULAR STRUCTURE OF THE AQUA- 
PORINS 
  The configuration of AQP1 reflects the common struc-
tural features of the AQP family with aminoacid similarity 
from 20% to 50%. The primary sequence of the cDNA re-
vealed that AQP protein monomer has a molecular weigh of 
around 30 kDa and subunits comprise six alpha-helix trans-
membrane domains with an inverted symmetry between the 
first and last three domains [76]. The two connecting loops, 
between transmembrane helices 2-3 and 5-6 contain an ami-
noacid triplet with the sequence Asn-Pro-Ala (NPA) con-
served across members of the AQP family and implied in 
pore formation and water selectivity Fig. (1A) [1, 9]. 
  Biochemical and freeze fracture studies have indicated 
that, as with other channel like membrane proteins, func-
tional AQPs assemble in cell membranes as tetramers with 
intracellular N- and C-termini [1, 95]. However, in contrast 
to most ion channel, the permeation pathway does not reside 
at the axis of symmetry formed by the four constituent 
subunits, but rather each subunit monomer contains separate 
pores [93]. Thus, each fully assembled AQP contains four 
channels for water permeation Fig. (1B).  
  The pore narrows midway between the leaflets of the 
bilayer to approximately between 3 and 6 Å diameter [37]. 
The specificity for water seems to be due to the diameter of 
the pore [33]. Moreover, because under different physiologic 
stimuli, water may be taken up or released by cells, the mo-
lecular architecture for a water-selective transporter must 
explain bi-directionality.  
  The molecular basis for AQP substrate specificity has 
been also widely investigated and it was demonstrated that, 
in spite of a general highly conserved structure, differences 
at the key area of the AQP sequence are responsible for the 
differences in channel selectivity [28, 51]. This variability at 
the primary structure defines two constriction points within 
the pore, referred to as the NPA constriction and the aro-
matic/arginine selectivity filter, respectively and the selec-
tion is done through mechanisms of charge, polar and size 
exclusions [38]. 
5. REGULATION OF AQUAPORIN PERMEATION 
  Although the movement of water through AQPs is   
primarily driven by osmotic gradients, there is evidence   
that permeation can be modulated by external factors.  
  AQP3 permeability is reduced at acidic pH, whereas the 
water and ion permeability of AQP6 is enhanced under simi-
lar condition [39, 102, 103]. Furthermore, it has been re-
ported that the water permeability of AQP4 is reduced fol-
lowing protein kinase C activation [34] and that AQP1 could 
be gated by cyclic GMP [6, 13]. Aquaporin Biology and Nervous System  Current Neuropharmacology, 2010, Vol. 8, No. 2    99 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic representation of the common AQP structure 
(A); tetrameric arrangement of AQP membrane. Each monomer has 
a water pore (B). 
  It has long been known that water transport in many cells 
is sensitive to inhibition by mercury-containing compounds, 
and the permeability of many human AQPs is also affected 
by these substances. Early studies demonstrated that AQP1 
has a cysteine residue (C189) near the NPA motif and its 
mutation to serine results in a loss of inhibition by mercury 
[78]. Similar pore loop cysteine residues are present in other 
mercury-sensitive AQPs [50]. By contrast, the mercury in-
sensitive aquaporin, AQP4, lacks cysteines at any of known 
mercury-sensitive sites [44]. 
  Because of its toxicity and other pharmacological actions, 
mercury is not the ideal inhibitor to characterize AQP func-
tion. Unfortunately, there are only few other agents that in-
hibits AQPs: silver salts inhibit AQP1 [70]; tetraethyl am-
monium, which is widely used as a blocker of potassium 
channels, blocks AQP1 [16]; and phloretin is a relatively 
potent inhibitor of several AQPs, including AQP9 [92]. 
However, phloretin lacks specificity, exhibiting inhibitory 
activity against solute transporters, as well as channels [24]. 
  The absence of good pharmacological modulators has 
presented a challenge for defining the function of AQPs   
in physiological and pathophysiological processes. Indeed, 
much of what is known about AQP function has been deter-
mined using non-pharmacological strategies. mRNA and 
protein expression studies have helped to define potential 
roles by characterizing tissue, cellular and subcellular AQP 
localization. The association of genes encoding AQPs with 
human hereditary disorders has also aided understanding of 
AQP function. Some of the most significant advances in de-
fining physiological functions for water-conducting channel 
have come from the detailed phenotype analysis of trans-
genic mice lacking genes encoding AQPs. 
6. LOCALIZATION AND FUNCTIONAL ROLES OF 
AQUAPORIN IN MAMMALS 
  AQPs are relatively ubiquitous in mammalian organism 
and are usually not restricted to a sole tissue [95]. However, 
their specific distribution in certain cell types of an organ 
often reflects a precise function. Because they increase water 
membrane permeability, AQPs are important actors of fluid 
homeostasis maintenance and secretion/re-absorption. 
  AQP0 is present in the eye lens and its mutation pro-
vokes cataracts formation [94]. AQP1, the first characterized 
AQP, is mostly expressed in red blood cells, kidneys, pe-
ripheral and central nervous system (CNS), lungs and is as-
sociated with water re-absorption and fluid secretion [14]. 
AQP1 knock-out mice and humans with AQP1 mutation 
have shown reduced urinary concentration [45, 56]. AQP2 is 
permeable to water and is expressed in kidney collecting 
duct [95]; its mutations can cause an autosomal form of he-
reditary nephrogenic diabetes insipidus in humans [21]. In 
addition, recent data reported the expression of AQP2 iso-
form also in the nervous system [15, 17]. AQP3 is also ex-
pressed in different tissues including kidney collecting duct, 
skin, conjunctiva of the eye, oesophagus, colon, spleen, 
stomach, small intestine, urinary bladder and respiratory tract 
airway epithelium. It is permeable to water and glycerol and 
may be important for proper skin hydration and elasticity 
[81, 95]. Mice lacking AQP3 manifest nephrogenic diabetes 
insipidus with polyuria, polydipsia, and urinary hypoosmo-
lality [96]. AQP4 is permeable to water and expressed in 
astroglial cells at blood–brain barrier and spinal cord, kidney 
collecting duct, glandular epithelia, airways, skeletal muscle, 
stomach and retina [95]. In the brain, AQP4 null mice 
showed altered cerebral water balance with protection from 
brain edema [58]. AQP5 is permeable to water and expressed 
in glandular epithelia, corneal epithelium, alveolar epithe-
lium and gastrointestinal tract [95]. Saliva production in the 
parotid gland is a sympathetically controlled phenomenon 
which involves the re-localization of AQP5 into the plasma 
membrane of the secretory cells [42]. The important role of 
AQP5 in homeostasis is evidenced by AQP5 knock-out mice 
which have reduced fluid secretions [95]. Defective cellular 
trafficking of AQP5 in salivary [89] and lacrimal [91] glands 
has been associated to the Sjörgren's syndrome, an autoim-
mune disease characterized by deficient secretion of tears 
and saliva. AQP6 is thought to be involved in chloride per-
meability and is expressed in kidney collecting duct interca-
lated cells [95]. AQP7 is involved in water and glycerol 
permeability and is expressed mainly in adipose tissue, and 
in testis, heart, skeletal muscle and kidney proximal tubule 
[95]. In adipocytes, AQP7 is known to facilitate the secretion 
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of fat accumulation and glucose metabolism [80]. AQP8 is 
permeable to water and is expressed in liver, pancreas intes-
tine, salivary gland, testis and heart [95]. It was suggested to 
be involved in cAMP stimulated bile secretion by Garcia and 
colleagues [30]. AQP9 is expressed in liver, white blood 
cells, testis and brain, and is involved in water and small 
solutes permeability [95]. The functional role of AQP9 in the 
brain is still unknown, but its permeability to glycerol and 
lactate indicates that it may play a role in energy metabolism 
[5, 90]. Studies performed with mice lacking AQP9 and 
leptin receptor function, developed obese mice, with type II 
diabetes and increased lipolysis and glycerol production 
[82]. AQP10 is thought to be involved in water and glycerol 
permeability and is expressed in small intestine [95]. AQP11 
is expressed in kidney, testis, liver, brain, intestine, heart, 
and adipose tissue, but its function is still unknown [31, 81, 
95]. AQP12 seems to be expressed specifically in pancreatic 
acinar cells, and as well as AQP0 and AQP11, it has not 
been characterized functionally. AQP12 knock-out mice 
have not been generated, and no human diseases have been 
credited to mutations in the AQP12 gene [81, 95]. The in-
volvement of AQPs in many human diseases such as glau-
coma, obesity or cancer, is now well reported. Indeed, AQPs 
are strongly expressed in tumour cells and promote cell mi-
gration [84]. Migration is a fundamental property of cells 
that occurs during many physiological and pathological 
processes including organogenesis in the embryo, repair of 
damaged tissue after injury, the inflammatory response, for-
mation of new blood vessels, and the spread of cancer. AQP 
dependent cell migration has been found in a variety of cell 
types in vitro and in mice in vivo [75]. AQP1 deletion re-
duces endothelial cell migration, limiting tumour angiogene-
sis and growth. AQP4 deletion slows the migration of reac-
tive astrocytes, impairing glial scarring after brain stab in-
jury. AQPs are conducive to migration by facilitating the 
rapid cell volume changes and augmenting cell propulsion. 
The emerging roles of water movement in cell migration are 
not only important in the mechanistic understanding of the 
migration process, but may also have a wide range of thera-
peutic implications [75]. Thus, the modification of AQP 
function or expression constitutes a promising target to de-
velop new drugs and provide a treatment of several diseases 
[97].  
7. AQUAPORINS IN THE NERVOUS SYSTEM 
  Several recent studies have shown that AQPs are impor-
tant in the nervous system homeostasis and neuronal signal-
ing. The AQP family in the CNS has diverse functions   
including that of a bidirectional water pathway between   
the brain and blood vessels, cerebrospinal fluid formation 
(CSF), neural signal transduction, osmoreception and some 
pathophysiological conditions [52]. To date, only some   
AQP subtypes (AQP1, 3, 4, 5, 8, 9) have been reported in the 
CNS being identified in choroidal cells (AQP1), astrocytes 
(AQP1, 3, 4, 5, 8, 9), oligodendrocytes (AQP8), neurons 
(AQP1, 5, 8), tanycytes (AQP9) and ependymal cells 
(AQP1, 4, 9) [8, 52, 59, 60, 67].  
  In contrast to numerous studies of AQP localization and 
function in the CNS, little information is available on the 
expression and function of AQPs in peripheral nervous   
system (PNS). 
7.1. AQP1 
  In rodents AQP1 is found on epithelial cells of choroids 
plexus, where it was concentrated at the apical pole [59, 68] 
and plays a role in CSF [73]. AQP1 is up-regulated in chor-
oids plexus tumours [55], which are associated with in-
creased CSF production, against supporting a role for this 
isoform in CSF secretion. AQP1 is not found in normal brain 
capillary endothelium, although highly expressed in periph-
eral endothelial cells [23, 68]. Cerebral capillary endothelial 
cells cultured in the absence of astrocytes [23] and capillary 
endothelial cells within the brain tumours (which are not 
surrounded by astrocyte end-feet) express AQP1 [83]. These 
observations suggest that astrocyte end-feet may signal adja-
cent endothelial cells to switch of endothelial AQP1 expres-
sion. 
  Moreover, recently a novel role of AQP1 in spinal cord 
injury was reported. In particular, they reported that constant 
hypoxic conditions in chronically injured spinal cords persis-
tently elevate AQP1 in neurons, ependymal cells, astrocytes, 
and sensory fibers and so may contribute to different   
pathological condition after spinal cord injury, such as   
neuronal/axonal swelling, over-production of CSF and for-
mation of cysts, or excessive axonal sprouting underlying the 
development of neuropathic pain and autonomic dysreflexia 
[64].  
  Regarding its distribution in PNS AQP1 is found in small 
diameter sensory neurons in dorsal root, trigeminal and no-
dose ganglia, but studies of a possible role for AQP1 in pain 
sensation remains to be determined [74, 86]. Moreover, ex-
pression of AQP1 protein was found in glial cells of the PNS 
where have extensive roles in regulating extracellular con-
centration of ions, metabolites and neurotransmitters [88]. 
Increasing evidence indicates that glial cells function to co-
ordinate the differentiation, metabolism and excitability of 
neurons, to modulate synaptic transmission and to integrate 
signals emanating from neurons and other glial cells [7, 25]. 
In addition, AQP1 expression in these may provide a mem-
brane marker to distinguish these cells from glial cells of the 
CNS that express AQP4 and AQP9 [29]. 
  Other recent studies have demonstrated the presence of 
neuronal elements for AQP1 in the enteric nervous system 
[62] and in the mechanoreceptive Ruffini endings in the 
periodontal ligament [63]. 
7.2. AQP4 
  AQP4 is the principal isoform in mammalian brain. It 
was first cloned from rat lung tissue [36] and shown to be 
expressed strongly in brain [101]. AQP4 is expressed in as-
trocytes and ependymal cells throughout the brain and spinal 
cord, particularly at the sites of fluid transport at the pial and 
ependymal surfaces in contact with the CSF in the subarach-
noid space and the ventricular system [67, 79]. Polarized 
AQP4 expression is found in astrocytic foot process in direct 
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is high in gray matter where numerous AQP4 dense process 
are found in direct contact with neuronal cell bodies and 
synapses [72, 99]. Verkman and co-workers [98] reported 
three distinct roles of AQP4 in brain function by phenotype 
analysis of AQP4 knock-out mice: the involvement in brain 
edema, in glial cell migration and in neuronal sign transduc-
tion. In particular, AQP4 facilitates clinically important wa-
ter movement into and out of the brain in the development 
and resolution of brain edema and modulation of AQP4 ex-
pression or function is also predicted to modulate glial scar 
formation, which may be of clinical utility in traumatic in-
jury, tumour and infection; moreover, recent data suggest 
increase extracellular space volume in AQP4 deficiency and 
impaired K
+ reuptake by AQP4-null astrocytes, which may 
be related to functional significant AQP4-K
+ channel interac-
tions [12].  
7.3. AQP9 
  AQP9 is a subtype mainly expressed in liver and testis 
having characteristics of being permeable to various solutes, 
including glycerol and lactate and this subtype might have a 
role in energy metabolism, as demonstrated by its presence 
in mitochondrial inner membranes [4]. In the brain, this wa-
ter and solute channel is present in the cells surrounding the 
cerebral ventricules, including ependymal cells and the tany-
cytes [10], and is expressed in astrocytes, brain stem 
catecholaminergic neurons [9] and subsets of midbrain do-
paminergic and hypothalamic neurons [4]. A recently evi-
dence of the presence of tetrameric AQP9 in brain and of 
expression in neurons has been provided by the analysis of 
mice with targeted deletion of AQP9 gene [61]. 
  In general, AQP9 expression becomes up-regulated in 
several brain diseases [10], for example in astrocytes border-
ing cerebral infarcts in mice [90]. Moreover, similarity of 
distribution pattern within the brain between AQP4 and 
AQP9 in mice and rats suggest that the two proteins mediate 
common function, and can act in synergy contributing to the 
facilitation of water movements between CSF and brain pa-
renchyma [10]. 
7.4. Other Aquaporins 
  Reverse transcription-polymerase chain reaction showed 
expression of AQP3, AQP5 and AQP8 in neuronal primary 
cultures and astrocyte cultures. Whereas microglial cells did 
not express AQP in rat brain, AQP8 was observed in oli-
godendrocytes and AQP5 in astrocytes [100]. Moreover 
AQP8 was detected primarily in ependymal cells lining the 
fluid-filled central canal of mouse spinal cord [72]. Never-
theless, the physiological role of this protein remains to be 
determined. 
  A new role of AQP2 isoform in PNS has recently been 
established. The data showed, for the first time, the expres-
sion of this protein in trigeminal and dorsal root ganglia   
in response to pain stimuli and in particular, respectively, 
inflammatory and neuropathic pain [15, 17].  
8. AQUAPORINS: A PROMISING TARGET FOR 
DRUG DEVELOPMENT 
  Water transport is a fundamental process contributing to 
human physiology and pathophysiology. Therefore, target 
pharmacological modulation of water and solute transport 
using AQPs would appear to provide novel opportunities for 
therapeutic treatments in a variety of human diseases, such 
as brain edema, glaucoma, tumour growth, congestive heart 
failure and obesity. 
  To date, there are few pharmacological modulators of 
AQPs available, and those that are known lack specificity or 
are toxic. Furthermore, the broad tissue expression of AQP 
subtypes in human will probably necessitate the identifica-
tion and development of subtype-selective AQP modulators. 
  Discovering new AQP modulators presents a challenge 
because screening strategies commonly used in the pharma-
ceutical industry to identify modulators of ion channels, G-
protein-coupled receptors and enzymes might not be appro-
priate for water channels. Moreover, there are not known 
specific high-affinity ligands for AQPs that can be used in 
radioligand binding assays.  
  To date, there are increasing of evidence that AQPs allow 
the passage of metalloid compounds; in fact, trivalent arsenic 
an antimony compounds, at physiological pH, behave as 
molecular mimics of glycerol and are conducted through 
AQP channels. Despite their toxicity, both metalloids are 
used as chemotherapeutic agents for the treatment of cancer, 
so the understanding of the factors that modulate AQP ex-
pression will provide a new approach to metalloid based 
chemotherapy [11]. 
  Moreover, recent data suggest the potential use of some 
recent therapeutic approaches, such as RNA interference 
(RNAi) and immunotherapy [27].  
  An intriguing issue is how the expression of AQPs is 
modified by drugs used for the treatment of brain edema 
caused by trauma, tumour and cerebral haemorrhage, but its 
mechanism of action is not known [49]. In a recent study, 
RNAi technology has been used to specifically suppress 
AQP4 expression in astrocytes primary cultures and so to 
elucidate its functional role in glial cells [65, 66]. Although it 
is unlikely that RNAi could be used as an efficient drug to 
rapidly block astrocytes swelling, AQP4 inhibition studies 
by RNAi in animals will be very useful to test the hypothesis 
that the inhibition of AQP4 activity is a potential target   
for the treatment of brain edema. Moreover, RNAi could be 
used to inhibit other AQPs expression in those pathologies 
where long term overexpression occurs, such as in tumour 
angiogenesis. 
  To date, it is still necessary to develop specific strategies 
for the discovery of potent pharmacological modulators that 
may be used as reversible AQP blockers and agents that tar-
get AQPs in specific tissues. 
CONCLUSION 
  Future research should clarify the physiological roles of 
AQPs in different tissues and cells where the role is not yet 
obvious. An important direction of study is represented by 
evaluation of new methods for diagnosis and therapy dis-
eases in veterinary and human medicine based on progress in 
understanding the precise cellular localization and the regu-
lation of the expression of these water channels in various 
cells.  102    Current Neuropharmacology, 2010, Vol. 8, No. 2  Buffoli Barbara 
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